Cargando…
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway
Despite gemcitabine being the leading chemotherapeutic drug for pancreatic cancer, many patients still relapse due to the drug resistance. We previously reported the molecular link between FKBP51 mediated AKT inhibition and gemcitabine response in pancreatic cancers. However, the upstream regulator...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377638/ https://www.ncbi.nlm.nih.gov/pubmed/30770779 http://dx.doi.org/10.1038/s41419-019-1326-6 |